Status:
COMPLETED
Relationship and Pathophysiology of Gastroesophageal Reflux and Dental/Periodontal Disease
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Takeda Pharmaceuticals North America, Inc.
Conditions:
Gastroesophageal Reflux
Dental Erosion
Eligibility:
All Genders
9-18 years
Brief Summary
This study investigates the prevalence and pathophysiology of dental and periodontal involvement in pediatric patients with symptomatic or asymptomatic gastroesophageal reflux (GER) or gastroesophagea...
Eligibility Criteria
Inclusion
- Ages 9.0 to 18.0 years, of either gender
- Able to give verbal / written assent / consent themselves and/or informed consent from a parent/guardian
- Willing to comply with all study procedures and protocols,
- Willing to get dental photographs and impressions taken
- Willing to sign the "Authorization for Release of Personal Health Information and Use of Personally Unidentified Study Data for Research" form
Exclusion
- Subjects suffering from systemic diseases, significant past or medical history with conditions that may affect oral health or oral flora (i.e. diabetes, HIV, heart conditions that require antibiotic prophylaxis)
- Other conditions that may decrease the likelihood of adhering to study protocol,
- Subjects who will leave the area and are unable to complete the study.
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT01167543
Start Date
September 1 2005
End Date
November 1 2008
Last Update
July 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco Dental School
San Francisco, California, United States, 94143